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ABSTRACT
We propose a new methodology for selecting and ranking covariates associated with a variable
of interest in a context of high-dimensional data under dependence but few observations. The
methodology successively intertwines the clustering of covariates, decorrelation of covariates using
Factor Latent Analysis, selection using aggregation of adapted methods and finally ranking. A
simulation study shows the interest of the decorrelation inside the different clusters of covariates.
We first apply our method to transcriptomic data of 37 patients with advanced non-small-cell lung
cancer who have received chemotherapy, to select the transcriptomic covariates that explain the
survival outcome of the treatment. Secondly, we apply our method to 79 breast tumor samples
to define patient profiles for a new metastatic biomarker and associated gene network in order to
personalize the treatments.
KEYWORDS
Aggregated methods; Correlated covariates selection; Genetic profiles; High dimension; Multiple
testing procedures; Personalized medicine; Ranking; Variable selection.
1. Introduction
The purpose of personalized medicine is to select appropriate and optimal therapies based on the
context of a patient’s genetic content or other molecular or cellular analysis. One of the main
challenges faced by biologist and mathematician consortium for the construction of explanatory
models of multivariable biological processes, is the relatively low amount of experimental data
available compared to the huge number of variables. The point is of great concern when the biological
question deals with transcriptomic data in order to build gene networks and decipher the role of
a rare isoform, for which no specific probe is currently available. In that context, the purpose of
this paper is to propose a method to select the covariates that are linked with the outcome of a
given therapy or a biological marker, among a set of more than tens of thousands covariates. For
instance, the relevant dataset we will study in this paper are the following:
• 51336 transcriptomic data of 37 patients with advanced non-small-cell lung cancer who have
received chemotherapy. The survival time being known, the objective is to select the tran-
scriptomic covariates that explain the survival outcome of the treatment, then to define the
profiles of the patients who survive the treatment.
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• 54676 probes in 79 breast tumor samples. A new metastatic biomarker being known, the ob-
jective is to define patient profiles for this metastatic biomarker, and associated gene network
in order to personalize the treatments.
The variable of interest being known (treatment outcome or biological marker), the question is
to find its link with the transcriptomic profile of the patients. We propose a methodology, that,
firstly selects and ranks the transcriptomic covariates that are the most linked with the outcome
treatment, and secondly, that visualises the profiles of the selected transcriptomic covariates, for
all the patients of the study.
More generally, the problem to detect association between a variable of interest and many
covariates has been tackled by many biologists and statisticians [2, 3, 11, 18, 19]. A common
example, coming from biology, is testing which of p genes’ expression levels given in a dataset X
is linked significantly with a variable Y , which we will call the variable of interest. The variable of
interest may be a binary variable like an outcome of treatment or it may be a quantitative variable
such as a phenotype or physiological parameter. In the two data studies of this paper, the aim
of the biologist is not necessarily to detect exhaustively all the genes involved in his problem but
to have a list of the most important of them in order to study their biological functions. For this
purpose, it is interesting to rank the genes according to the strength of their link with the variable
of interest. Although we present biological studies, our goal is to propose a general methodology in
a context of high dimensional data (the number p of covariates is in the order of thousands) while
the total number n of samples could be small (for instance between 25 and 100).
In the context of transcriptomic data, the covariates are high dimensional and correlated. This
correlation between covariates, in a high-dimensional context, has to be taken into account in the
statistical analysis. Moreover, we are in a context of small sample size (n  p). Thus, robustness
of the statistical analysis has to be quantified.
We cite here some statistical methods that have been developed to select covariates in high-
dimensional contexts. The state of the art about the control of false discoveries in multiple testing
procedures is very extensive. The famous correction proposed by [6] to control the Family Wise Error
Rate (FWER) has been emulated and we can find a review about these methods in [10]. Alternative
methods focused on the control of the False Discovery Rate (FDR) ([4, 5]), or of the local FDR
[12] or the q-value [26–28]. For a review (in french) of the methods, see [3]. Regarding regression
in the framework of high dimensional data (n p), many methods are available. For exemple, the
PLS approach of [30] is a kind of principal component regression. The Lasso regression proposed
by [32] performs both variable selection and regularization in penalizing the sums of squares by
the L1-norm of the coefficients. This method has been derived for many kinds of problems like
logistic-regression in the case of binary data [21], or network inference [22]. Another versatile tool
to select covariates in different non parametric contexts is given by the random forests, with the
concept of importance of covariates [16].
Another important characteristic of the data that has to be taken into account is the structure
of covariance of the covariates. Most of the multiple testing corrections make the assumption of
the independence between the tests. However it is well-known that omics data are correlated by
blocks. In the context of multiple testing, covariance between the covariates could bias the uniform
repartition of the p-values under the null hypothesis and also inflates the variance of the estimation
of the FDR [14, 15]. In [16] it is also shown that despite the robustness of the random forests,
importance of covariates calculated by random forests is perturbed by adding other correlated
covariates. One of the ways to deal with dependence is to model it by latent factors; it is a way
to reduce the information in supposing that the common information of the p covariates is given
by q  p latent factors as [15] and [14]. More precisely, they propose a way to correct the data
according to a regression link with the variable of interest Y in such a way that covariates are
independent conditionally to Y (leading to the independence of the tests). After this correction,
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they propose a multiple testing procedure based on the method of [4] and [5]. This method of
correction will be called FAMT correction (for Factor Analysis for Multiple Testing) in the sequel.
However, the framework of FAMT is to consider the data X as an only one block of correlated
covariates and has to be adapted if X is structured in several independent clusters of correlated
covariates. As we will see in Section 3, the FAMT does not give good results if it is applied
directly on the whole set of data X, without taking into account its decomposition in clusters with
strong within correlation. Then, we propose to identify the clusters of correlated covariates before
performing FAMT correction on each of the clusters. The clustering of covariates as proposed by [9]
is a good way to arrange covariates into homogeneous clusters, i.e., groups inside of which covariates
are strongly related to each other.
Our purpose in this paper is to propose a method adapted to the selection (and ranking) of
correlated quantitative covariates associated with a variable of interest. For this, we propose a
methodology that takes into account (1) the structure of correlation by clusters of covariates; (2)
the correlation inside each cluster of correlated covariates.
Our methodology is divided in two steps: a pretreatment of the covariates (step 1) and a
procedure of selection of the pretreated covariates (step 2). The pretreatment consists of (step 1.1)
detecting the clusters of covariates by using the clustering of covariates proposed by [9], and (step
1.2) applying a ”decorrelation” between the covariates inside each cluster using the factor analysis
proposed by [7, 14, 15]. Their method performs a decorrelation of the covariates and calculates the
corrected covariates suitable for statistical testing and/or regression.
After that pretreatment, we propose a procedure to select and rank the covariates, by combin-
ing different selection methods that take into account the nature of the outcome Y (qualitative
or quantitative) and the high dimensional context (multiple testing procedures for the tests, pe-
nalised regression, ...). We define a score for each covariate, which is defined by the number of
selections among all the selection methods involved in this step. This score can be used to classify
the covariates like in [29].
The paper is organized as follows. In Section 2, we detail the model and explain the principle
of the main steps of our methodology: the pretreatment of the covariates and the construction of
the covariates scores of selection. Section 3 is dedicated to simulations studies in order to assess
the interest of the proposed pretreatment on one hand and the good working of the whole selection
strategy on the other hand. The simulations are performed in the case where the variable of interest
is binary. Section 4 is dedicated to two real data analysis: the purpose of the first analysis is to select
covariates that are linked with the outcome of a lung cancer treatment, whereas the second analysis
selects covariates linked with a breast cancer biomarker. In both analysis, the selected covariates
are used to define genetic profiles of patients. Section 5 gives some conclusions and perspectives.
The Appendix gives two simulation studies in the case where the variable of interest is respectively
a binary and a continuous quantitative variable (Sections A and B of Appendix). Technical details
on the two real data applications are also given (Sections C and D of the Appendix).
2. Methodology
2.1. Framework and model
We suppose that we have n i.i.d replications of (Y,X) where Y is the variable of interest, and
X = (X1, X2, . . . , Xp) is the vector of covariates, taking its values in Rp. We make the assumption
that the covariates are decomposed into K independent clusters:
X = (X
(1)
1 , . . . , X
(1)
p1︸ ︷︷ ︸
X(1)
, . . . , . . . , X
(k)
i , . . .︸ ︷︷ ︸
X(k)
, . . . , . . . , X(K)pK︸ ︷︷ ︸
X(K)
) = (X(1), . . . ,X(K)),
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where p1 + . . .+ pK = p.
On one hand, we model the dependence in the K clusters of covariates as in the framework
of [15]: inside each cluster X(k), the common information between the pk covariates is modeled by
regression on qk latent factors:
X
(k)
i = δ
(k)
i (Y ) + b
(k)
i Z
(k) + ε
(k)
i , for i = 1, . . . , pk, (1)
where δ
(k)
i (Y ) is a function of Y , Z
(k) is a random centered qk-vector such that E(Z(k)Z(k)
′
) = Iqk ,
b
(k)
i is a qk-vector, and ε
(k) = (ε
(k)
1 , . . . , ε
(k)
pk ) is a random centered pk-vector with independent com-
ponents, and independent of Z(k). The common information contained in X(k) is then concentrated
in a small dimension space by qk latent factors Z
(k). Under the model (1), we have:
Σ(k) := V(X(k)|Y ) = B(k)(B(k))′ + Ψ(k) (2)
V(X(k)|Y,Z(k)) = Ψ(k) (3)
Cov(ε(k)i , Z
(k)
j ) = 0, ∀i, j, k (4)
where Ψ(k) is a diagonal pk× pk matrix (the covariance matrix of ε(k)) and B(k) is a pk× qk matrix
of factor loadings b
(k)
i (cf Equation (1), the b
(k)
i being the ith row of B
(k)). In the decomposition
given in Equation (2), the diagonal element Ψ
(k)
i is the specific variance of the response X
(k)
i while
B(k)(B(k))′ appears as the shared variance in the common factor structure. [15] define the common
variance by
ComVar(k) =
trace(B(k)(B(k))′)
trace(Σ(k))
. (5)
On the other hand, we suppose that the specific informations at each cluster (that is vectors
(Z(k), ε(k))1≤k≤K) are independent, then, given Y , the covariance matrix of the whole vector of
covariates has the form given by the Figure 1.
2.2. Main prodecure
The procedure is decomposed in two steps: a pretreatment of the covariates (step 1) and a selection
method of the covariates (step 2).
2.2.1. Step 1: pretreatment of data (clustering of covariates and decorrelation inside clusters).
The aim of this pretreatment is to perform a decorrelation of the covariates, to obtain corrected
covariates that are suitable for testing and/or regression. Indeed, the correlation between covariates
has an impact on all the classical selection procedures: the conventional methods, namely the
multiple testing procedures (the p-value adjustment methods proposed by [6], [4, 5], or the q-value
proposed by [26–28], or the local FDR presented in [2], [3]) are all built on the assumption that
tests are independent. As a results, they are no longer promising if the independence is not verified.
A very detailed discussion can be found in the Friguet’s thesis [13].
In estimating together the latent factors Z(k) and the coefficients of regressions (B(k),Ψ(k)) by
an E.M. algorithm in model (1), the FAMT procedure of [15] can correct the covariates such that
they are almost independent and as a result, suitable for multiple testing procedures or selection by
regression or random forests. More precisely, the corrected data, noted X
(k)?
i = X
(k)
i − b(k)i Z(k) =
4
δ
(k)
i (Y ) + ε
(k)
i , i = 1, . . . , pk, lead to a standard multiple regression problem where the errors ε
(k)
i
are independent. Note that this correction of the data X is done conditionally on the variable of
interest Y [15].
Of course, the whole vector X satisfies assumption of Equation (1), and [15] apply this decor-
relation procedure on the whole set of covariates X. But instead of applying Friguet’s procedure
on the whole set of covariates X, we propose to first detect the different clusters (X(k))1≤k≤K and
then to apply the decorrelation method on each cluster. Indeed, [25] has shown with some sim-
ulation studies that the decorrelation was degraded by the dimension of the vector of covariates,
whereas it was better after the detection of the independent clusters. By this way, the covariates
selection procedure can be highly improved by clustering of covariates (step 1.1) before applying
factor analysis to correct the correlation within each cluster (step 1.2), as it is shown in Section 3.
2.2.1.1. Step 1.1: clustering of covariates. We apply a clustering of covariates in the purpose
to find clusters of correlated variables as we assumed in Section 2.1. We propose to use the algorithm
of [9] to cluster covariates into homogeneous clusters and thus to reveal structures. This algorithm
maximizes an homogeneity criterion, where the homogeneity of a cluster is defined by the sum of
squared Pearson correlations between the covariates present in the cluster and the first principal
component of this cluster. This algorithm is expected to roughly find the highly correlated clusters
of covariates as we assumed in the Section 2.1. The procedure proposes also a method (based on
bootstrap resampling) to find the number K of clusters if it is unknown.
2.2.1.2. Step 1.2: Factor analysis to correct dependency structure in each cluster. As
already explained in the beginning of this section, clustering is followed by decorrelation inside each
cluster using the Friguet’s procedure.
At the end of this pretreatment procedure, we obtain corrected data, noted X∗Y in the sequel.
Note that X∗Y depends on Y . To simplify the notations, X
∗
Y will be noted X
∗.
2.2.2. Step 2: Aggregation of statistical methods applied on the resulting dataset.
The statistical methods proposed in this part are not fixed and can be adapted by the practitioner
according to its preferred selection methods and the characteristics of the data (nature of variable
of interest Y , samples’ sizes and so on).
The idea is the following: we choose several methods to select the pretreated covariates X?. We
perform L methods, then each covariate X?i obtains a score Si ∈ {0, 1, . . . , L} that is the number
of selections among the L methods. By this way, the covariates can be ranked according to their
link with the outcome Y .
For instance, in the examples developed in our simulation studies and in real data, Y is binary,
the size of the samples are low and we choose eight different methods of selection: five different
multiple testing procedures applied to the Wilcoxon test (Bonferroni, Benjamin-Hochberg, q-values,
local FDR, FAMT), logistic regression penalised by Lasso, and two selections by random forests
(threshold step and interpret step, see [16]). The outcomes of this procedure are the scores Si, i =
1, . . . , p which are integers included in [0, 8]. For example, if Si = 8, then the corresponding variable
has been selected by all the eight methods, whereas if Si = 0, the corresponding variable has been
selected by none of them. The scores can be used to rank the covariates according to the strength
of their link with the variable of interest.
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2.3. R Package armada
In the sequel, we call our procedure ARMADA for AggRegated Methods for covAriates selection
under Dependence. Our procedure has been implemented in an R package, called armada, available
on the CRAN [23]. The package proposes also a graphical representation of the selected covariates,
through heatmaps, as presented in Figures 5 and 8.
3. Simulations
We first explain the simulation design in Section 3.1. We then describe the effect of the pretreatment
in Section 3.2 and finally, we study the selection procedure in Section 3.3.
3.1. Simulation design
We propose a simulation study with p = 1600 covariates and sample size n = 60. We first describe
how to create dependence in the covariates X, then we present a simulation design in a classification
study. Two other designs in classification and regression cases are given in Sections A and B of the
Appendix.
The covariates X = (X(k))k=1,...,4 are clustered into four independent clusters, each of them
containing pk = 400 covariates. For this, before to model the dependence with the outcome Y , we
generate for each cluster k, a preliminary vector X˜(k) that is a gaussian 400-vector, with mean 0
and non-diagonal variance-covariance matrix Σ(k). The correlation between the covariates of X˜(k)
inside the cluster k is designed by a factor analysis model described in Equation (2). More precisions
on the simulation procedure of data with covariance design defined by Equation (2) can be found
in [13]. We simulate data with common variances ComVar(k) equal to 0.8 in each cluster (recall
that the common variance is defined in Equation (5)). Moreover, the numbers of latent factors in
each cluster are (q(1), . . . , q(4)) = (4, 6, 8, 10).
Now, we create the dependence between X and Y in perturbing some component of X˜. We
consider an equiprobable two-class problem, Y ∈ {0, 1} (i.e. Y = 1 for n2 subjects, and Y = 0 for n2
subjects). Y is linked with 160 influential covariates in X, whose links with the response variable Y
have different intensities. The other covariates are noise. More precisely, in each cluster k = 1, . . . , 4,
and for i = 1, . . . , 400,
X
(k)
i = X˜
(k)
i + δi1Y=0
with δ = (δi)i=1,...,400 = (1.5, . . . , 1.5︸ ︷︷ ︸
i=1,...,10
, 1, . . . , 1︸ ︷︷ ︸
i=11,...,20
, 0.75, . . . , 0.75︸ ︷︷ ︸
i=21,...,30
, 0.5, . . . , 0.5︸ ︷︷ ︸
i=31,...,40
, 0, . . . , 0︸ ︷︷ ︸
i=41,...,400
). In other words,
Y is linked with the m1 = 40 first covariates of each cluster, and the m0 = 360 remaining covariates
of each cluster are independent of Y . Then, the 10 first covariates of each cluster are the most
strongly linked with the response variable Y and the strength of the link is decreasing in the
successive groups of 10 influential covariates.
We can remark that this design respects the covariance matrix given in Figure 1 and the model
given by Equation (1).
3.2. Interest of our data pretreatment
In order to emphasize the interest of our data pretreatment, we compare the results of a Wilcoxon
test after three different data pretreatments:
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Procedure 1: nothing is done on the dataset X.
Procedure 2: the covariates X are decorrelated, taking Y into account, with the factor analysis procedure
of [7, 15], implemented in the R package FAMT. This gives a new dataset X†Y .
Procedure 3: the 4 clusters are estimated with the procedure of [9], implemented in the R package
ClustOfVar; then the covariates are decorrelated in each cluster, taking Y into account,
with the factor analysis procedure of [7, 15], implemented in the R package FAMT. This gives
a new dataset X∗Y obtained by the concatenation of the decorrelated clusters.
Remark: our data pretreatment is the Procedure 3. We have supposed that the number of
clusters is known. If that is not the case, the user can choose its own number of clusters by using
the graphical tools of the ClustOfVar procedure (plots of the dendrogram).
Our objective is to find out the differently expressed covariates in the two groups (groups Y = 0
and Y = 1) with sample sizes n2 = 30. For this, we perform Wilcoxon tests on each of the p
pretreated covariates of the dataset (that is X for Procedure 1, X†Y for Procedure 2, X
∗
Y for
Procedure 3), given a three sets of p p-values. For each of these procedures, the selected covariates
are those with p-values lower than 0.05. We compare these procedures on N = 100 runs of (X, Y ).
For the comparison, we count the number of influential covariates that are correctly detected (this
number is noted TP, for True Positive), this indicator gives an idea of the sensibility of the test after
the procedure. To assess the specificity, we count the number of non-influential detected covariates
(this number is noted FP, for False Positive). Note that the perfect method would detect all the
influential covariates (that is 160 here) and no False Positive. However, according to the detection
threshold chosen for the p-value, the expected number of FP is 72 = 5%× (1600−160). The results
are shown in Figure 2.
On the Figure 2, we can see that Procedure 1 is in fact the one that has the lowest rate of
FP but its power is also the poorest. Our Procedure reduces the mean and the variability of the
distributions of the false positive rates, in comparison to the Procedure 2 (i.e. the FAMT procedure).
The power of our Procedure is comparable with Procedure 2. This results show the interest of our
proposed pretreatment before performing selection.
3.3. Results of the whole method (pretreatment and selection)
In order to describe the performances of our method, we show in Figure 3 the mean ARMADA
scores obtained on the N = 100 runs of (X, Y ) for each design. The scores are given for all the
covariates individually, and also by group of influential and noise covariates (the groups of influential
covariates are noted by ”1.5”, ”1”, ”0.75”, ”0.5” (see Section 3.1); the group of noise covariates is
noted by ”-”).
We can see on the Figure 3 that the scores give a clear ranking of the covariates, according
to the strength of their link with the response variable Y . The highest scores are obtained by the
covariates which are the most strongly linked with the response variable Y . The ARMADA method
is performant: the mean score clearly distinguishes the five groups of covariates according to their
link with Y . The distribution of the individual scores inside each group is given by the boxplots.
The ARMADA scores clearly separate the influential covariates from the others; and inside the
influential covariates the two first groups are clearly separated of the last one. Note that around
95% of the noise covariates obtained an ARMADA score that was exactly 0.
3.4. Comparison with other selection methods
We propose the following selection criterion in our procedure: the selected covariates are those with
scores greater or equal to 1.
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Figure 1. Covariance structure of covariates given Y
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Figure 2. Number of true positive tests (left), false positive tests (right) according to the different pretreatment procedures
(1: Nothing, 2: FAMT, 3: clustering followed by FAMT in each cluster). Dotted lines: expected number of FP. Boxplots are
calculated on N = 100 runs.
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Figure 3. Left: mean of the ARMADA scores obtained by all the covariates. Right: boxplot of the scores of the covariates,
ranked by levels of link with Y . Means and boxplots are calculated on N = 100 runs.
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We compare this selection procedure with two other selection methods:
• the Wilcoxon test: the selected covariates are those with raw-pvalues (i.e. p-values without
any correction) lower than 0.05,
• the FAMT procedure [7]: the selected covariates are those with adjusted p-values lower than
0.05.
To compare the three selection methods, the Table 1 gives the rates of selection for each group
of influential covariates, and for the group of noise covariates. The rates of selection have been
computed on N = 100 runs of (X, Y ). We can see that our method respects the expected rate of
false positives that is not the case for the FAMT method which exhibits a greater rate of 10 %.
Moreover, our method gives the best results. The rate of selection of the influential covariates is
very good compared with the other methods even if the strength of the link is poor.
Table 1. Results of the N = 100 runs: rates
of selection of the different groups of influential
and noise covariates by the ARMADA method,
the Wilcoxon test and the FAMT procedure. The
corresponding standard deviations are given in
brackets.
ARMADA Wilcoxon FAMT
1.5 0.99 (0.04) 0.99 (0.07) 0.99 (0.02)
1 0.97 (0.15) 0.85 (0.35) 0.95 (0.20)
0.75 0.91 (0.27) 0.62 (0.48) 0.82 (0.38)
0.5 0.79 (0.40) 0.33 (0.47) 0.52 (0.49)
- 0.05 (0.23) 0.05 (0.22) 0.10 (0.30)
Finally, we can conclude with the ROC curves given in Figure A3 that our method outperforms
the two others selection methods (the ordinates of the points of the ARMADA ROC curve are all
higher than the ordinates of the points of the two other ROC curves). The ROC curves have been
obtained by the mean of the N = 100 ROC curves obtained in the N = 100 runs of (X, Y ).
0.0 0.2 0.4 0.6 0.8 1.0
0.
0
0.
4
0.
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Figure 4. ROC curves for the three selection methods.
4. Application to real data
In this section we apply our method on two real datasets, both in oncology. The first one concerns
the selection of transcriptomic covariates linked with the outcome of a chemotherapy for lung
cancer. The second one concerns the selection of covariates linked with a quantitative biomarker
ERα36 in breast cancer.
9
4.1. Outcome of chemotherapy for advanced non-small-cell lung cancer
We apply our method on transcriptomic data of n = 37 patients with advanced non-small-cell lung
cancer, who have received chemotherapy. Even if we are aware of the fact that chemotherapy is
not a target therapy, the problematic is really to select suitable transcriptomic covariates in the
purpose to detect profiles associated with the effect of a treatment. For each patient, we have
51336 transcriptomic covariates, and its survival status: 24 patients whose death occurred before
12 months and 13 patients whose death occurred after 12 months. This criteria of death before
one year is very common in clinical trials. We applied a first filtering of the covariates, where we
decided to ignore the covariates for which the Wilcoxon test does not detect a difference between
the 24 patients whose survival time is lower than 12 months and the 13 other ones (we eliminate
covariates with Wilcoxon-pvalue greater than 0.05). After this filtering we obtained a dataset with
n = 37 patients and p = 6810 covariates. In the pretreatment step, we found that the p = 6810
covariates are decomposed in 3 independent group of covariates.
In a first time, the biological question was to find the genes which can explain a survival time
greater or lower than 12 months. We then consider a binary response variable Y : Y = 1 for the 24
patients whose survival time is lower than 12 months and Y = 0 for the 13 patients whose survival
time is greater than 12 months. The response variable being binary, we first applied the selection
method presented in Section 2.2.2.
Moreover, as the survival time was known for all the 37 patients without any censoring, we also
apply our method on the same dataset (6810 covariates) but here, Y is the survival time. We then
have a regression problem. We have used eight selection methods in Step 2 of our method: five
different multiple testing procedures applied to the Pearson correlation test (Bonferroni, Benjamin-
Hochberg, q-values, local FDR, FAMT), regression penalised by Lasso, and two selections by ran-
dom forests (threshold step and interpret step, see [16]).
The joint results of the classification and regression studies are given in Table 2. In the clas-
sification study, we can see that 10 covariates are particularly important, with a score equal to 7,
whereas 2827 covariates have a score equal to 0, and 3983 covariates have a score greater or equal
to 1. It is clear that, the biologist will not focus on the 3983 covariates with a positive score. But
the method clearly gives a hierarchy between the genes and it is sure that the function of the 10
genes with a score at 7 has to be studied to understand its link with the ”success” of the treatment.
The table 2 is a little disappointing, because regression and classification do not select the same
covariates. Whatever, among the covariates with a C-score (score in the classification case) equal
to 7, there is only one with a R-score (score in the regression case) lower than 4 (equal to 0!). But
these two analyses are not looking for the same kind of link with the covariates. Moreover, these two
approaches give two tools to detect influential covariates. We can combine these two approaches
and consider the covariates that are selected by at least one approach, or consider the covariates
that are selected by both of them. In the Figure 5, we show the heatmap of the selected covariates
which have a classification score and a regression score greater than five. For the visualisation of the
results, we then build an heatmap obtained thanks to the R package heatmaply after co-clustering
of the survival times (on the x-axis) and of the covariates (on the y-axis) with the function hclust
(Figure 5).
The visualisation of the co-clustering of the selected genes and the survival leads to the distinc-
tion of three different groups of patients (noted P1, P2, P3 in Figure 5) of respective sizes 7, 8, 22
from the left to the right of the x-axis. The co-clustering identifies also two clusters of genes (noted
G1 and G2 for simplicity). All the people except 2 of the two first group P1 and P2 have a life status
Y = 1 (among the two exceptions, one is at the threshold with a survival of 11.5 months), all of the
people of the third group P3 have a life status Y = 0. The selected covariates clearly discriminates
groups P1 and P3. Indeed, the patients of the group P1 have a low expression of the covariates in
G1 and a high expression of the covariates in G2 and the inverse for group P3. Patients of group
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Table 2. Repartition of the covariates scores in the transcriptomic
dataset. The R-scores are given in the 9 rows, the C-scores are given
in the 8 columns. For instance, 41 covariates have a R-score equal to 1,
and a C-score equal to 0.
Classification score
Regression score 0 1 2 3 4 5 6 7
0 2227 328 273 337 531 257 34 1
1 41 7 3 9 17 10 2 0
2 131 35 39 52 119 71 9 0
3 119 48 44 50 117 114 17 0
4 174 65 56 86 256 241 102 4
5 119 64 40 57 116 176 116 4
6 15 4 4 5 12 19 26 1
7 1 2 1 0 1 0 0 0
8 0 0 0 0 1 0 0 0
G1	
G2	
P1	 P2	 P3	
Figure 5. Heatmap of the 342 covariates which have ARMADA scores greater or equal to 5 in both classification and
regression studies. Each column corresponds to one patient. The x-axis represents the patients (marked with their survival
time) and the y-axis the covariates. Color gives the normalised expression of the covariates.
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P2 have intermediate expressions according the two others groups.
As the number of patients n = 37 is small compared to the number of covariates even after
filtering (p = 6810), we have checked our results with a bootstrap study. The results (reported in the
Section C of the Appendix) show that our method is robust: the distributions of the bootstrapped
scores faithfully reproduce the original scores.
4.2. Biological network involving ERα36 in breast cancer
ERα36 is a variant of the oestrogen receptor α encoded by the ESR1 locus and expressed only in
humans [33]. ERα36 expression and activity have been mainly studied in vitro and in vivo in the
context of breast cancer. However, due to the lack of comprehensive transcriptomic data that include
ERα36, only sparse information is available on factors that could act up- and downstream ERα36
in biological networks. Our challenge from a statistical point of view was to explain the ERα36
expression variation obtained in a small number of breast tumors from a large number of potential
explanatory variables that correspond to the 54676 transcriptomic probes. For this, we analysed
the biological network involving ERα36 through the use of 4 sets of Affymetrix transcriptomic
data obtained from breast tumors of different molecular subtypes: the triple negative (noted TN),
ERa66+, PR+ and PR- datasets (details are provided in Section D of the Appendix).
The analysis was performed in three steps (Figure 6).
	
«	Complete	»	datasets	
79	tumors		
54676	probes	(Affymetrix	U133	array)	
	
46	
«	ERa66+	»	
16	
«	PR-	»	
29	
	«	PR+	»	
17	
«	TN	»	
Step	1	:	Experimental	measurement	of	ERa36	expression	level		(RT-qPCR)	
Step	2a	:	slecOon	of	a	probeset	linked	to	ERa36	
	ARMADA		algorithm	
277	
probes	
711	
probes	
319	
probes	
369	
probes	
Step	2b	:		
FuncOonal	analysis	
MSigDB	(GSEA)		
Step	2c	:		
Experimental	validaOon	
Step	3	:	Molecular	signatures	associated	to	ERa36	expression	
	
4	
classes	
2	
classes	
3	
classes	
3	
classes	
Figure 6. Workflow describing the 3 steps of four breast tumor transcriptomic datasets.
Step 1, clinical data completion. These 4 transcriptomic datasets were completed by the mea-
surement of ERα36 expression level in each tumor. Biological details are given in Section D of the
Appendix.
Step 2a, statistical analysis. To explain the ERα36 expression variation obtained in a small
number of tumors from a large number of potential explanatory variables, we used the R package
armada, in its regression version (as in Section 4.1 where Y is quantitative), that allowed to select,
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among the 54676 initial probes, a few hundreds of genes whose expression is supposed to be corre-
lated to that of ERα36 (ARMADA score ≥ 1). We obtained four lists of respectively 711, 277, 319
and 369 probes correlated to the expression of ERα36 in the TN, ERa66+, PR+ and PR- groups.
Step 2b, functional analysis. From these four lists of transcriptomic probes, we carried out a
functional analysis using the MSigDB database (GSEA). In particular, we looked for transcription
factors and microRNAs involved in the regulation of the majority of genes from the different
lists (TN, ERa66+, PR+ and PR-). The results indicated that four transcription factors: NFAT,
FOXO4, SP1 and LEF-1, were common regulators and could therefore be mediators of the ERα36
effect in all breast tumor subtypes. Interestingly, a study by [1] has shown that these transcription
factors FOXO4, SP1 and LEF-1 are transcriptional hallmarks characteristic of cancer cells and
associated to the Wnt signaling pathway (involved in metastasis and maintenance of cancer stem
cells). Regarding the analysis of microRNAs, the results indicated that the majority of the genes
whose expression correlated to ERα36 one in the TN set were regulated by the microRNAs: hsa-
miR-106B, hsa-miR21 and hsa-miR-29A, listed as oncogenic microRNAs involved in metastatic
processes, survival and self-sufficiency in growth factors of mammary tumors [20]. These results
recalled those of a previous study of [8], which showed that a high ERα36 expression in mammary
tumors is associated with an increased metastatic potential and an estrogen-independent tumor
growth.
Step 2c, experimental validation. Subsequently, we provided an experimental confirmation of
the biological reliability of the results: the correlation between the expression of ERα36 and that of
ZEB1, FZD7, ZIC1 and TCF7LD genes, identified by armada as correlated to ERα36 in all tumor
sets, was verified in vitro by RT-qPCR in two breast cancer cell lines (MCF-7 (ERa66+, PR+, PR-)
and MDA-MB-231 (TN)). The results of Figure 7 confirmed the correlation (positive or negative)
between the expression of ERα36 and that of the genes identified by armada in the both cell lines.
Figure 7. Experimental validation of biological data inferred from armada. (A) ERα36 expression level as measured by RT-
qPCR in MCF-7 and MDA-MB-231 breast cancer cells. (B) TCF7L1, ZEB1, FZD7 and ZIC1 expression level as measured by
RT-qPCR in MCF-7 and MDA-MB-231 breast cancer cells.
Step 3, tumor classification according to ERα36 expression level. The final goal of our
study was to identify the molecular signatures accounting for the ERα36 expression level in the four
different sets of tumors. These signatures were identified thanks to the R package heatmaply after
co-clustering of the ERα36 expression (on the x-axis) and of the covariates (on the y-axis) with the
function hclust. For each of the four tumor datasets, a heatmap was built which accounted for the
expression level of the genes correlated to ERα36. Thanks to the associated dendogram, different
classes of tumors were defined and characterized by both the level of ERα36 expression and an
associated molecular signature. The Figure 8 illustrates the results for the study on the dataset
ERa66+: two classes of tumors were identified, called ERα36++ and ERα36−. Taken together, the
armada package helped to cluster patients which breast tumor highly express ERα36 and associated
genes. These patients could be treated by Wnt signaling inhibitors or specific microARN modulators
and therefore benefit such promising new personalized medicine.
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Figure 8. Heatmap of the 711 covariates which have ARMADA scores greater or equal to 1 in the study of the dataset ERa66+.
Each column corresponds to one ERa66+ tumor. The x-axis represents the tumors (marked with their ERα36 expression level)
and the y-axis represents the selected probes. Color gives the normalised expression of the covariates.
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5. Conclusion and perspectives
We have proposed a new methodology which is able to select the covariates (here the genes) that
are linked with a variable of interest (here the treatment of an outcome or a biological marker). The
method is of particular interest in the high dimensional case and when the covariates are correlated.
The algorithms corresponding to this method are available through the R package armada. After
this selection obtained with our method, it is then easy to visualise the selected genes (or probes)
for all the patients, and to classify the genetic profiles of patients with respect to their treatment
outcome or biological marker. In the study of the treatment by chemotherapy in the advanced non-
small-cell lung cancer, we have identify three types of genetic profiles defined with two clusters of
genes. In the study of the mammary tumors, the covariates selection allows the biologist to study
the functional role of selected probes and also to classify tumors and associated transcriptomic
signatures. This kind of results is very promising for the identification of new therapeutic targets
and the development of more efficient and personalized anti-cancer treatment.
Appendix
The Appendix gives additional simulations on another classification model, and on a regression
model where Y is a continuous quantitative variable (Sections A and B of Appendix), some further
analysis of the lung cancer data presented in Section 4.1 (Section C of Appendix), and technical
informations on the biological material used in Section 4.2 (Section D of Appendix).
Appendix A. Classification design
A.1. Simulation design
As in Section 3, we propose a simulation study with p = 1600 covariates and sample size n = 60.
The response variable Y is binary: Y = 1 for n2 subjects, and Y = 0 for
n
2 subjects. The covariates
X = (X(k))k=1,...,4 are clustered into four independent clusters, each of them containing pk = 400
covariates. For this, before to model the dependence with the outcome Y , we generate for each
cluster k, a preliminary vector X˜(k) that is a gaussian 400-vector, with mean 0 and non-diagonal
variance-covariance matrix Σ(k). The correlation between the covariates of X˜(k) inside the cluster
k is designed by a factor analysis model, as in the Section 3. More precisions on the factor analysis
model can be found in [13]. Now, we create the dependence between X and Y in perturbing some
component of X˜. This simulation design is inspired from the toys-data of [16]. The outcome Y is
linked with 240 influential covariates in X, the others being noise covariates. The links between the
influential covariates and the response variable Y have different intensities. More precisely, the 10
first covariates of each cluster are the most strongly linked with the response variable Y and the
strength of the link is decreasing in the successive groups of 10 influential covariates.
More precisely, let us define the simulation model by giving the conditional distribution of Xi
given the value y of Y : in each cluster k = 1, . . . , 4, and for i = 1, . . . , 400,
X
(k)
i = X˜
(k)
i + δ
(k)
i (y)
where δi(y) is a random variable.
• The relevant covariates are the m1 = 60 first covariates of each cluster. The distribution of
the δ
(k)
i (y) leading to the links between the relevant covariates and Y is given in Table A1.
15
• The m0 = 340 remaining covariates of each cluster are independent of Y : δ(k)i (y) = 0 whatever
y for i = 61, . . . , 400.
Table A1. Links between the relevant covariates and
Y in the classification design. The notation δ
(k)
i ∼
0.7N (3y, 1) + 0.3N (0, 1) means that, with probabil-
ity 0.7, δ
(k)
i ∼ N (3y, 1), and with probability 0.3,
δ
(k)
i ∼ N (0, 1).
i model for δki
for i = 1, . . . , 10 δ
(k)
i ∼ 0.7N (3y, 1) + 0.3N (0, 1)
for i = 11, . . . , 20 δ
(k)
i ∼ 0.7N (2y, 1) + 0.3N (0, 1)
for i = 21, . . . , 30 δ
(k)
i ∼ 0.7N (y, 1) + 0.3N (0, 1)
for i = 31, . . . , 40 δ
(k)
i ∼ 0.3N (3y, 1) + 0.7N (0, 1)
for i = 41, . . . , 50 δ
(k)
i ∼ 0.3N (2y, 1) + 0.7N (0, 1)
for i = 51, . . . , 60 δ
(k)
i ∼ 0.3N (y, 1) + 0.7N (0, 1)
We can remark that this design respects the covariance matrix given in Figure 1. This design
differs a little bit from the model of Equation (1), because δ
(k)
i (Y ) is a random function of Y . Note
that in real data analysis, we don’t know the model from which they are generated. It is why it is
interesting to analyse the performance of our method on different kinds of simulated data.
A.2. Interest of our data pretreatment
In order to emphasize the interest of our data pretreatment, we compare the results of a Wilcoxon
test after three different data pretreatments:
Procedure 1: nothing is done on the dataset X.
Procedure 2: the covariates X are decorrelated, taking Y into account, with the factor analysis procedure
of [7, 15], implemented in the R package FAMT. This gives a new dataset X†Y .
Procedure 3: the 4 clusters are estimated with the procedure of [9], implemented in the R package
ClustOfVar; then the covariates are decorrelated in each cluster, taking Y into account,
with the factor analysis procedure of [7, 15], implemented in the R package FAMT. This gives
a new dataset X∗Y obtained by the concatenation of the decorrelated clusters.
Remark: our data pretreatment is the Procedure 3. We have supposed that the number of
clusters is known. If that is not the case, the user can choose its own number of clusters by using
the graphical tools of the ClustOfVar procedure (plots of the dendrogram).
Our objective is to find out the differently expressed covariates in the two groups (groups Y = 0
and Y = 1) with sample sizes n2 = 30. For this, we perform Wilcoxon tests on each of the p
pretreated covariates of the dataset (that is X for Procedure 1, X†Y for Procedure 2, X
∗
Y for
Procedure 3), given a three sets of p p-values. For each of these procedures, the selected covariates
are those with p-values lower than 0.05. We compare these procedures on N = 100 runs of (X, Y ).
For the comparison, we count the number of influential covariates that are correctly detected (this
number is noted TP, for True Positive), this indicator gives an idea of the sensibility of the test after
the procedure. To assess the specificity, we count the number of non-influential detected covariates
(this number is noted FP, for False Positive). Note that the perfect method would detect all the
influential covariates (that is 240 in this study) and no False Positive. However, according to the
detection threshold chosen for the p-value, the expected number of FP is 68 = 5%× (1600− 240).
The results are shown in Figure A1.
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Figure A1. Number of true positive tests (top), false positive tests (bottom) in the classification design according to the
different pretreatment procedures (1: Nothing, 2: FAMT, 3: clustering followed by FAMT in each cluster). Dotted lines: expected
number of FP. Boxplots are calculated on N = 100 runs.
If we analyse the results given by Figure A1, we can see that Procedure 1 is in fact the one that
has the lowest rate of FP but its power is also the poorest whatever the design. Our Procedure
reduces the mean and the variability of the distributions of the false positive rates, in compar-
ison to the Procedure 2 (i.e. the FAMT procedure). The power of our Procedure is comparable
with Procedure 2. This results show the interest of our proposed pretreatment before performing
selection.
A.3. Results of the whole method (pretreatment and selection)
In order to describe the performances of our method, we show in Figure A2 the mean ARMADA
scores obtained on the N = 100 runs of (X, Y ). The scores are given for all the covariates individ-
ually, and also by group of influential and noise covariates (the groups of influential covariates are
noted by ”(0.7,3)”, ”(0.7,2)”, ”(0.7,1)”, etc.; the group of noise covariates is noted by ”-”).
We can see on the Figure A2 that the scores give a clear ranking of the covariates, according
to the strength of their link with the response variable Y . The highest scores are obtained by the
covariates which are the most strongly linked with the response variable Y . The method is not so
performant as in the design presented in Section 3, probably because we are note exactly in the
model of the study, given by Equation (1), but also because the strength of the link with Y is low
excepted for the two first groups of covariates that have scores which are well separated from the
others by the selection method. We can precise that around 95% of the noise covariates obtained
an ARMADA score that was exactly 0.
A.4. Comparison with other selection methods
We propose the following selection criterion in our procedure: the selected covariates are those with
scores greater or equal to 1.
We compare this selection procedure with two other selection methods:
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Figure A2. Top: mean of the ARMADA scores obtained by all the covariates. Bottom: boxplot of the scores of the covariates,
ranked by levels of link with Y . Means and boxplots are calculated on N = 100 runs. Simulation in the classification design.
• the Wilcoxon test: the selected covariates are those with raw-pvalues (i.e. p-values without
any correction) lower than 0.05,
• the FAMT procedure [7]: the selected covariates are those with adjusted p-values lower than
0.05.
To compare the three selection methods, the Table A2 gives the rates of selection for each
group of influential covariates, and for the group of noise covariates. The rates of selection have
been computed on N = 100 runs of (X, Y ). We can see that our method respect the expected rate
of false positives that is not the case for the FAMT method which exhibits a greater rate of 10 %.
Our method is competitive with the FAMT procedure for the detection of influential covariates,
but again FAMT procedure has more false positives than ours.
Table A2. Results of the N = 100 runs in the clas-
sification design: rates of selection of the different
groups of influential and noise covariates by the AR-
MADA method, the Wilcoxon test and the FAMT
procedure. The corresponding standard deviations
are given in brackets.
ARMADA Wilcoxon FAMT
(0.7-3) 0.99 (0.08) 0.99 (0.07) 0.99 (0.04)
(0.7-2) 0.92 (0.27) 0.92 (0.26) 0.96 (0.17)
(0.7-1) 0.44 (0.49) 0.43 (0.49) 0.58 (0.49)
(0.3-3) 0.54 (0.49) 0.41 (0.49) 0.61 (0.48)
(0.3-2) 0.32 (0.46) 0.28 (0.45) 0.41 (0.49)
(0.3-1) 0.12 (0.32) 0.12 (0.33) 0.19 (0.39)
- 0.05 (0.23) 0.05 (0.22) 0.09 (0.29)
Finally, we can conclude with the ROC curves given in Figure A3 that our method outperforms
the two others selection methods (the ordinates of the points of the ARMADA ROC curve are all
higher than the ordinates of the points of the two other ROC curves). Note that the ROC curves give
the impression that our method is not competitive with the two others, but this is only caused by
the fact that we have traced a solid line between the points (1-specificity, sensibility)ARMADA score=0
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and (1-specificity, sensibility)ARMADA score=1. The ROC curves have been obtained by the mean of
the N = 100 ROC curves obtained in the N = 100 runs of (X, Y ).
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Figure A3. ROC curves for the three selection methods in the classification design.
Appendix B. Regression design
In this section, we give results of simulations to study the behavior of our algorithm to select
covariates linked with a continuous variable of interest (like survival time here). We simulate X˜ =
(X˜(k))k=1,...,4 as in Section 3, and Y as a standard gaussian variable. Now, we create the dependence
with outcome Y in perturbing some component of X˜: in all cluster k = 1, . . . , 4, and for all i =
1, . . . , 400:
X
(k)
i = X˜
(k)
i + δiY (B1)
where δ = (δj)j=1,...,400 = (1, 0.8, 0.6, 0.4, 0.2, 0, 0, . . . , 0). Only the first 5 covariates of each cluster
are linked with Y .
We show the interest of our pretreatment, comparing the three procedures detailed in Section
3. As Y is a gaussian variable, we use the Pearson correlation test (instead of the Wilcoxon test
used in Section 3). We produce N = 100 runs of (X, Y ) and count the number of false and true
positive, and the ARMADA scores (shown in Figures B1 and B2).
Similarly to the classification studies presented in Section 3, our Procedure reduces the mean
and the variability of the distributions of the false positive rates, in comparison to the Procedure
2 (i.e. the FAMTprocedure), and the power of our Procedure is comparable with Procedure 2.
The Figure B2 shows the ARMADA scores obtained on these N = 100 runs of (X, Y ). Again,
similarly to the Section 3, the scores give a ranking of the covariates, according to the intensity of
their link with respect to the response variable Y . The true covariates are clearly separated of the
noise covariates. We can also precise that 96% of the noise covariates obtained a score that was 0.
As in Section 3, the Table B1 and the ROC curve in Figure B3 allow us to compare our method
with the Pearson test and the FAMT procedure. Our method seems to be a good compromise
to have quite good detection rates for the true covariates, but small detection rates for the noise
covariates. Even though true covariates are not always enough detected, compared to the FAMT
procedure, detection rate of noisy covariates is lower than FAMT. The Pearson test has the lowest
levels of detection rates, and the true covariates with a small link with Y are not well detected. On
the whole, our method seems to be appropriate for sparse models particularly when the goal is to
avoid false positive detections.
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Figure B1. Number of: true positive tests (top), false positive tests (bottom) in the regression design. Boxplots are calculated
on N = 100 runs.
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Figure B2. Top: mean of the ARMADA scores obtained by all the covariates. Bottom: boxplot of the scores of the covariates,
ranked by levels of link with Y . Means and boxplots are calculated on N = 100 runs. Simulation in the regression design.
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Figure B3. ROC curves for the three selection methods, in the case of regression design. The ROC curves have been obtained
by the mean of the N = 100 ROC curves obtained in the N = 100 runs of (X, Y ).
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Table B1. Results of the N = 100 runs in the
regression design: rates of selection of the differ-
ent groups of influential and noise covariates by
the ARMADA method, the Pearson correlation
test and the FAMT procedure. The correspond-
ing standard deviations are given in brackets.
ARMADA Pearson FAMT
1 1 (0) 1 (0) 1 (0)
0.8 1 (0) 1 (0) 1 (0)
0.6 0.99 (0.08) 0.99 (0.08) 1 (0)
0.4 0.97 (0.18) 0.82 (0.38) 0.98 (0.13)
0.2 0.67 (0.47) 0.33 (0.47) 0.76 (0.43)
- 0.07 (0.26) 0.05 (0.22) 0.10 (0.30)
Appendix C. Lung cancer real dataset: bootstrap analysis
As the number of patients n = 37 is small compared to the number of covariates even after filtering
(p = 6810), we have checked our results with a bootstrap study. We have calculated the C-scores
and R-scores of each covariates on B = 100 bootstrap samples and the mean of the B results. We
give the distribution of the bootstrapped means according to the original scores for the original
dataset (Figure C1).
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Figure C1. Distribution of the bootstraped mean of C-scores (resp. R-scores), i.e. means of C-(or R-)scores obtained on
B = 100 bootstrap samples), according to the corresponding C-scores (resp. R-scores) in the original dataset for all the
p = 6810 covariates.
We can see that the distributions of the bootstrapped means of the scores have a quite small dis-
persion and faithfully reproduce the original scores. The same conclusion holds for the bootstrapped
median scores (shown in Tables C1 and C2).
Moreover, we can emphasis that our method is robust to detect the most important covariates
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Table C1. Distribution of the boostraped median C-scores of the p = 6810 covari-
ates, obtained on B = 100 boostrap samples, versus the corresponding C-scores.
ARMADA C-score
Bootstraped median C-score 0 1 2 3 4 5 6 7
0 2698 53 0 0 0 0 0 0
0.5 11 1 0 0 0 0 0 0
1 108 315 29 1 0 0 0 0
1.5 0 19 5 0 0 0 0 0
2 9 162 308 76 5 0 0 0
2.5 0 2 28 14 0 0 0 0
3 1 1 87 321 55 2 0 0
3.5 0 0 1 29 12 1 0 0
4 0 0 2 155 922 218 1 0
4.5 0 0 0 0 19 6 0 0
5 0 0 0 0 157 644 221 2
5.5 0 0 0 0 0 0 6 0
6 0 0 0 0 0 17 78 8
Table C2. Distribution of the boostraped median R-scores of the p = 6810 covariates,
obtained on B = 100 boostrap samples, versus the corresponding R-scores.
ARMADA C-score
Bootstraped median R-score 0 1 2 3 4 5 6 7 8
0 3773 29 11 0 0 0 0 0 0
0.5 20 2 5 0 0 0 0 0 0
1 67 22 17 0 0 0 0 0 0
1.5 8 1 9 0 0 0 0 0 0
2 109 32 243 40 1 0 0 0 0
2.5 4 0 22 8 2 0 0 0 0
3 7 3 147 295 80 2 0 0 0
3.5 0 0 0 14 13 2 0 0 0
4 0 0 2 149 788 210 0 0 0
4.5 0 0 0 0 10 14 0 0 0
5 0 0 0 3 90 462 85 5 0
5.5 0 0 0 0 0 1 0 0 0
6 0 0 0 0 0 1 1 0 1
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(for instance, the 10 covariates that have a C-score equal to 7, or the 6 covariates that have an
R-score greater than 7): their corresponding bootstraped means of scores are also high, and their
corresponding bootstraped median scores are greater than 5.
Appendix D. Biological material for the study of ERα36 in breast cancer
We analysed the biological network involving ERα36 through the use of 4 sets of Affymetrix tran-
scriptomic data obtained from breast tumors of different molecular subtypes: the triple negative
(noted TN), ER66+, PR+ and PR- datasets:
• the TN dataset corresponding to Affymetrix transcriptomic comprehensive data from 17
patients derived xenografts (PDX) breast tumors was extracted from the XentechTM
database with the permission of Olivier De´as and Stefano Cairo (MTA CXT-295 Xentech
SAS/University of Lorraine ; [24]).
• the 3 other datasets (46 tumors ER66+, 29 tumors PR+, 16 tumors PR-) were part of those
from the Carte d’Identite´ des Tumeurs Program (CIT) from the Ligue Nationale Contre
le Cancer described in [17]. Transcriptomic raw data were kindly provided by Aure´lien De
Reynies and Jacqueline Me´tral. One microgram of cDNAs from each tumor sample gathered at
the Oncogenetics laboratory, INSERM U735, Institut Curie-Hoˆpital-Centre Rene´ Huguenin,
St Cloud, France was also kindly provided by Ivan Bieche to measure ERα36 expression.
The measurement of ERα36 expression in each tumor (Step 1: clinical data completion) has
been done as described in [31]. Total RNA extraction of PDX samples and qPCR analyses were
performed. The following primers were used for qRT-PCR : GAPDH forward (Fw) 5’-TGC-ACC-
ACC-AAC-TGC-TTA-GC -3’, GAPDH reverse (Rev) 5’-GGC-ATG-GAC-TGT-GGT-CAT-GAG
-3’, ERα36 forward (Fw) 5’- ATG-AAT-CTG-CAG-GGA-GAG-GA-3’, ERα36 reverse (Rev) 5’-
GGC-TTT-AGA-CAC-GAG-GAA-ACC-3’. Assays were performed at least in triplicate, and the
mean values were used to calculate expression levels, using the ∆∆C(t) method referring to GAPDH
housekeeping gene expression.
Notes on contributors
The first case study of Section 4.1 comes from Transgene team thanks to B. Bastien. T. Boukhobza,
H. Dumond and C. Thiebaut conducted the biological study of Section 4.2 and performed the func-
tional analysis that follows the covariates selection with armada. S. Cairo and O. De´as ; XenTech,
Genopole, 91000 Evry (France) provided the TN dataset; A. De Reynies, I. Bieche and J. Me´tral
from the Carte d’Identite´ des Tumeurs program provided the access to transcriptomic raw data
and biological samples (ERa66+, PR+, PR- datasets). The statistical methodology has been de-
veloped by A. Ge´gout-Petit and A. Muller-Gueudin, and thanks to Y. Shi and H. Chakir during
their Master internships.
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